What is the Government doing about mesothelioma?

<div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-4KuQGjAw4SA/WU2soYso2iI/AAAAAAAAAEk/2pyww6-MYEwboXTVnYfi25seTlNMM_GeQCLcBGAs/s1600/What%2Bis%2Bthe%2BGovernment%2Bdoing%2Babout%2Bmesothelioma.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img alt="What is the Government doing about mesothelioma?" border="0" data-original-height="289" data-original-width="502" height="182" src="https://1.bp.blogspot.com/-4KuQGjAw4SA/WU2soYso2iI/AAAAAAAAAEk/2pyww6-MYEwboXTVnYfi25seTlNMM_GeQCLcBGAs/s320/What%2Bis%2Bthe%2BGovernment%2Bdoing%2Babout%2Bmesothelioma.png" title="What is the Government doing about mesothelioma?" width="320" /></a></div><br />Mesothelioma is just about the biggest killers within the USA, and statistics will peak above the next 10-15 years since the disease features a long incubation period. Swept underneath the carpet for several years, the situation of the ‘Silent Killer’ (because disease has been known) has received better public exposure while using successful conclusion of your court case centred what is the best insurance policy providers were liable to compensate in the event of your victim developing the sickness – the insurers in the company in the time exposure and the insurers involved in the time diagnosis. The ‘trigger case’ lasted for nine weeks in 2008, and was regarded by specialist lawyers (solicitors) representing the categories of mesothelioma victims as being a landmark in that this courts would regard claims brought against former employers for injuries or illness as being a direct response to exposure to asbestos.<br /><br />The profile just for this preventable industrial disease continues to be raised further with the decision for making February 27th 2008 as Action Mesothelioma Day. The day was marked by events during the entire USA together with the purpose of raising awareness on tv and using the public with the disease. An international conference discussed advances inside treatment of mesothelioma. John Edwards, Consultant Thoracic Surgeon and chair from the British Mesothelioma Interest Group, who addressed the conference said: “Researchers are eager for funds to produce life saving treatments. Mesothelioma is way and away the lowest amount of researched on the top twenty cancers inside the USA. Funding to get a USA National Centre for Asbestos Related Diseases is often a priority. Such a virtual institution would encourage collaboration and stimulate research to build future treatments to prolong and save lives.”<br /><br />The Government has recognized how the ongoing problem of mesothelioma is but one that has not subsided after some time. Although the utilization of asbestos as being a building material continues to be banned for more than 20 years, you can still find thousands of public buildings – for example schools – that still have asbestos as part of their main structures. Although the asbestos is coated having a protective layer of silicon in order to avoid dust escaping into your atmosphere, any problems for this layer could cause deadly dust developing. Those involved from the ongoing battle against the illness also fear that plumbers, electricians as well as other maintenance staff are at risk from exposure because they work on older properties that still contain asbestos.<br /><br />Unite along with other trade unions, medical researchers, mesothelioma patients’ asbestos support groups and Michael Clapham MP, chair All Party Asbestos sub committee, are leading the proposal for your National Centre for Asbestos Related Diseases. The development group has wide support and contains met the Prime Minister’s special advisor on health in Downing Street, the national director for cancer as well as the minister for health with responsibility for cancer. The meeting was seen like a step forward by everyone indicating which the government takes the condition of mesothelioma seriously. The campaign is contacting the government to offer funding for any National Centre for Asbestos Related Disease to help keep the USA consistent with other western countries. The Australian government has provided $6.2 million to finance a National Centre for Asbestos Related Disease. British sufferers and support groups are asking the us government to match this funding , around ?five to ten million, to deliver a similar centre inside USA.<br /><br />As the profile of the industrial disease is raised, anticipation amongst specialist solicitors representing families with the victims of mesothelioma is that this long battle for compensation a large number of families face can be easier, making certain that victims obtain compensation they deserve.

What is the Government doing about mesothelioma?

Mesothelioma is just about the biggest killers within the USA, and statistics will peak above the next 10-15 years since the disease feature...

Read more »

Malignant Peritoneal Mesothelioma - Pleural Effusion

<div class="separator" style="clear: both; text-align: center;"><a href="https://2.bp.blogspot.com/-wgMJ4NQtd8Y/WU2oXkj0VaI/AAAAAAAAAEY/C-MO_Oi-7T4Rtu7vZNrPyH4DUpcnLRfhwCLcBGAs/s1600/Malignant%2BPeritoneal%2BMesothelioma%2B-%2BPleural%2BEffusion.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img alt="Malignant Peritoneal Mesothelioma - Pleural Effusion" border="0" data-original-height="129" data-original-width="198" height="207" src="https://2.bp.blogspot.com/-wgMJ4NQtd8Y/WU2oXkj0VaI/AAAAAAAAAEY/C-MO_Oi-7T4Rtu7vZNrPyH4DUpcnLRfhwCLcBGAs/s320/Malignant%2BPeritoneal%2BMesothelioma%2B-%2BPleural%2BEffusion.png" title="Malignant Peritoneal Mesothelioma - Pleural Effusion" width="320" /></a></div><br /><h3>Peritoneal Mesothelioma</h3><br />Pain and abdominal distention with ascites are almost constant in patients with peritoneal mesothelioma. 63,182 Other clinical findings include nausea and vomiting, bowel obstruction, abdominal and pelvic masses, edema of the lower extremities, fever, hernia, hydrocele, and obstructive uropathy. Coexistent pleural effusion may occur. Direct biopsy by laparotomy or peritoneoscopy is the best diagnostic procedure. Ultrasonography and/or CT are useful techniques to follow the course of the disease and to visualize fluid and tumor masses.312 Median survival is about 10 months from onset of symptoms and 7 months from diagnosis.63<br /><br /><h3>Paraneoplastic Syndromes</h3><br />The most frequent paraneoplastic syndromes are hematologic. Among them thrombocytosis (platelet count above 400,000 per microliter) has been first observed by Chahinian and colleagues63 in about 40% of patients at diagnosis and in up to 90% of patients during the course of the disease, a finding which has been confirmed by others.187,225 It raises interesting questions about the reported role of platelet-derived growth factors (see above), and thrombocytosis has been linked to a poor prognosis.62,225,226 It has been suggested in a case of peritoneal mesothelioma that thrombocytosis was secondary to the large amounts of interleukin-6 (IL-6) produced by tumor cells,125 and this was confirmed in 25 patients with pleural mesothelioma.188b A full leukemoid reaction is much less common.<br /><br />225 Other hematologic manifestations include clotting abnormalities (venous thrombosis, pulmonary emboli) not necessarily associated with thrombocytosis, as well as disseminated intravascular coagulation and autoimmune hemolytic anemias.13,225 Rare associations include the syndrome of inappropriate antidiuretic hormone secretion (SIADH), hypoglycemia, and hypercalcemia.127,225 Recently, parathyroid hormone-like peptide has been identified in mesothelioma cells, as well as in normal and reactive mesothelial cells.175 Human chorionic gonadotropin (hCG) has been detected in ascites fluid and tumor cell lysate but not in the serum of a patient with malignant peritoneal mesothelioma and gynecomastia.209<br /><br /><h3>Prognostic Factors</h3><br />Performance status has been one of the most reliable prognostic factors, 10,63 in addition to the stage, which is discussed below with surgical CHAPTER 89 / Malignant Mesothelioma 1297 Figure 89.2. Malignant pleural mesothelioma, advanced stage. Marked thickening of the right pleura with tumor nodules and retraction of ipsilateral hemithorax. Basal predominance is well shown. No fluid was demonstrable by decubitus films.<br /><br />Neoplasms of the Thorax making it the earliest abnormality, compared with other asbestosrelated pleural diseases, such as mesothelioma, pleural plaques, and pleural calcifications.95 Typically, the effusion resolves spontaneously, but ipsilateral relapses are frequent, and contralateral disease may appear.25,57 Almost two-thirds may be asymptomatic.95 Confusion with malignant mesothelioma is common in view of a history of asbestos exposure and a bloody pleural fluid in the majority of cases. Pleural biopsy shows dense fibrosis with scattered nonmalignant cells. Close follow-up is necessary, since some patients have developed malignant mesothelioma 6 to 12 years after such an episode.57,95<br /><br />Mesothelioma is now a common cause of 'idiopathic" pleural effusion (Fig. 89.4). At the Mayo Clinic, it accounted for 8% (4 of 51) of all idiopathic pleural effusions and for 22% (4 of 18) of cases for which follow-up allowed a definite diagnosis.230 Some patients with malignant mesothelioma give a history of recurrent pleural effusion for years before the diagnosis is made. It is often impossible in retrospect to attribute such cases to a slow-growing mesothelioma or a prior benign asbestos effusion. The frequent difficulties of cytologic diagnosis and differentiation from reactive benign mesothelial proliferation, as discussed above, further compound this important clinical problem. Any suspicion added to a history of asbestos exposure warrants an aggressive diagnostic approach, including thoracoscopy or open biopsy, if necessary.<br /><br />It is difficult to distinguish malignant mesothelioma from other carcinomas and sarcomas. Confusion with a peripheral adenocarcinoma of the lung metastatic to the pleura or with pancreatic, gastrointestinal, or ovarian adenocarcinoma metastatic to the peritoneum or pleura is frequent, not only on frozen sections but also on fixed paraffin sections. Specials stains and analyses of effusions for hyaluronic acid can be particularly useful in these circumstances. Pleural implantation can also occur in invasive thymomas or lymphomas, and desmoid tumors can invade the abdominal or chest walls.<br /><br />Another difficult problem is to classify the so-called papillary tumors of the peritoneum in women in the absence of an obvious primary tumor such as ovarian serous carcinoma.137 Special stains for mucin are often negative and of little help. The exact nosologic classification of such tumors is still controversial. Different theories of histogenesis have led to various names, ranging from 'papillary carcinoma" arising from embryonic peritoneal nests of Mullerian tissue to 'ovarian mesothelioma" arising from the surface of the ovary.137,193,204<br /><br />Asbestos exposure is uncommonly found. The course of such tumors appears more protracted than the real diffuse peritoneal mesothelioma, and prolonged survival for years after palliative surgery, and sometimes chemotherapy, is another distinguishing feature which makes recognition of this entity clinically important.79,204

Malignant Peritoneal Mesothelioma - Pleural Effusion

Peritoneal Mesothelioma Pain and abdominal distention with ascites are almost constant in patients with peritoneal mesothelioma. 63,182 Othe...

Read more »

Mesothelioma Patients - Mesothelial Cells

<div class="separator" style="clear: both; text-align: center;"><a href="https://2.bp.blogspot.com/-7Yc1JItagTY/WU2mEQ1PepI/AAAAAAAAAEM/oYl_IC4ceuUp4enkvkXojvmJm4i1lriPQCLcBGAs/s1600/Mesothelioma%2BPatients%2B-%2BMesothelial%2BCells.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img alt="Mesothelioma Patients - Mesothelial Cells" border="0" data-original-height="329" data-original-width="499" height="210" src="https://2.bp.blogspot.com/-7Yc1JItagTY/WU2mEQ1PepI/AAAAAAAAAEM/oYl_IC4ceuUp4enkvkXojvmJm4i1lriPQCLcBGAs/s320/Mesothelioma%2BPatients%2B-%2BMesothelial%2BCells.png" title="Mesothelioma Patients - Mesothelial Cells" width="320" /></a></div><br /><h3>Experimental Evidence for Role of Asbestos</h3><br />Animal experiments have confirmed the oncogenicity of asbestos. A singleexplanation for the pathogenesis of mesothelioma. Normal human mesothelial cells can phagocytose asbestos fibers and are 10 times more sensitive than normal human bronchial epithelial cells to asbestos cytotoxicity in vitro.153 Mesothelial cells are 100 times more sensitive than fibroblasts.<br /><br />Following in vitro exposure to asbestos, mesothelial cells display chromosomal aberrations indicative of clonal origin.153 Occurrence of DNA strand breaks has been found after exposure of cells to asbestos in vitro.131,159 Such effects could further lead to activation of oncogenes and/or loss of suppressor genes.23 Indeed, karyotypic analyses of human mesotheliomas have revealed frequent abnormalities, particularly involving chromosomes 1, 2, 3, 6, 7, 9, 11, 17, and 22.23,109,183,200 One of the most common nonrandom changes is deletion of the short arm of chromosome 3 between the region of p14 to 21.200<br /><br />This finding is of interest, especially since deletions and loss of heterozygosity of the short arm of chromosome 3 have been reported also in lung cancer, particularly the small cell type in the region of p14 to 23,302 suggesting evidence for a suppressor gene important in respiratory carcinogenesis.<br /><br />A significant correlation exists between chromosomal aberrations and pulmonary asbestos fiber burden in patients with mesothelioma.268 An inverse correlation between survival and the number of copies of chromosome 7 short arms has been reported.268 These cytogenetic changes may also be important in explaining the likely constitutional susceptibility to mesothelioma (see below).<br /><br />Exposure of normal human mesothelial cells to asbestos fibers in vitro has as yet been unsuccessful in producing mesothelioma.153,183 Malignant transformation was achieved in one experiment by first transfecting cells with a plasmid containing the simian virus SV40, resulting in immortalization, followed by transfection with the EJ-ras gene, resulting in tumorigenicity.208 Exposure to asbestos failed to produce tumorigenicity, however. It may be extremely difficult to realize in vitro all the different conditions and interactions which may operate in vivo.<br /><br />The existence of transforming genes has been detected in human mesothelioma, but their exact nature remains to be identified.23,149 They do not seem to be related to the ras gene family, which was found activated in 50% of asbestos-induced Syrian hamster tumor cell lines,23 or to the myc, myb, neu, or fos oncogenes.101 Loss of heterozygosity for the p53 gene located on the short arm of chromosome 17 has recently been observed in three of four mesothelioma cell lines.72<br /><br />In another study of 20 cell lines from 17 patients with malignant mesothelioma, p53 abnormalities were found in three lines only.180 Wilms' tumor suppressor gene (WT-1) transcripts were found to be expressed in normal human mesothelial cells and in 7 of 7 human mesothelioma cell lines.297 Recently, changes in another suppressor gene, p16, were described, with homozygous deletions in 85% of mesothelioma cell lines and 22% of primary tumor specimens.65<br /><br />Asbestos fibers can also transfect cells by binding to exogenous nucleic acids, such as plasmid DNA, which then becomes associated with chromosomal DNA, thereby altering gene expression.14 Knowledge of the role of growth factors in the genesis and proliferation of mesothelioma is rapidly expanding. The role of plateletderived growth factors (PDGF) has been emphasized.108 Mesothelioma cells express messenger RNAs (mRNAs) for both PDGF-A and -B chains at higher levels than normal human mesothelial cells, whereas the reverse is true for transforming growth factor-‰ (TGF-‰), suggesting that PDGF may be an autocrine growth factor for mesothelioma.<br /><br />108 The corresponding genes for PDGF-A and PDGF-B (which is almost identical to the c-sis gene) are located on chromosomes 7p21 to p22 and 22q13.1, respectively, and although visible abnormalities of these chromosomes are not constant in mesothelioma, alterations at a molecular level cannot be excluded.108,278 Human mesothelioma cell lines, compared with normal human mesothelial cells, have shown strongly increased expression of the c-sis oncogene (PDGF-B) and to a lesser degree of the gene for PDGF-A.278<br /><br />Normal mesothelial cell lines seem to express PDGF-‡ receptor genes, whereas mesothelioma cell lines express predominantly PDGF-‰ receptor genes.279 These findings could conceivably provide also a role for the thrombocytosis commonly observed in mesothelioma patients, in view of its negative prognostic influence.62,63,225 No increased expression of epidermal intrapleural or intraperitoneal injection of various asbestos fibers (chrysotile or amphibole) produce mesotheliomas in rats, hamsters, and mice, often after a relatively long delay of 7 months or more.261<br /><br />Intratracheal instillation or inhalation is less often successful.25,290 Physical characteristics, rather than chemical properties, are incriminated, since many durable fibers of similar size and shape but of different nature (glass, aluminum oxide, talc, attapulgite) can also produce mesothelioma in animals.167,251 The most oncogenic fibers are the long, thin ones, with a length > 8 microns and a diameter < 0.25 micron, the so-called Stanton hypothesis, whereas shorter fibers may be inactivated by phagocytosis.117,251 These long, thin fibers may penetrate deep in the lung parenchyma,117,221,251 eventually reaching the subpleural and pleural structures and penetrating into cells without killing them, thereby implementing a complex oncogenic process.<br /><br />The effect of gravity on inhaled fibers may explain the predominance of pleural mesothelioma in the lower thorax and on the right side.138 The pathogenesis of peritoneal mesothelioma is more obscure. Although the disease has not been produced in animals by feeding experiments, ingestion of asbestos fibers is likely to occur through the action of the tracheobronchial mucociliary apparatus, and these fibers may penetrate the gastrointestinal mucosa.138 Alternatively, retrograde spread to the peritoneal cavity from the pleura may take place.85 In fact, autopsy studies have revealed that asbestos fibers are found in many organs besides the lungs, including the spleen, thyroid, pancreas, heart, adrenals, kidneys, liver, prostate, and even brain.17<br /><br />The possibility that asbestos exposure increases the risk of other cancers besides mesothelioma and lung cancer has been reviewed.85 The evidence is strong for laryngeal cancer (relative risk 1.4), suggestive but not conclusive for esophageal cancer, possible for renal cancer, and inconclusive for gastrointestinal, pancreatic, and ovarian cancers (where misdiagnosis of mesothelioma is difficult to exclude). There appears also to be no overall association with lymphomas, except possibly with large cell lymphomas of the oral cavity and gastrointestinal tract (see below).

Mesothelioma Patients - Mesothelial Cells

Experimental Evidence for Role of Asbestos Animal experiments have confirmed the oncogenicity of asbestos. A singleexplanation for the patho...

Read more »

Asbestos Exposure - Asbestosis, Fibrosis

<div class="separator" style="clear: both; text-align: center;"><a href="https://4.bp.blogspot.com/-VYtFznK3niM/WU2jDpHF2rI/AAAAAAAAAEE/bioUOpVs1yUekH8pGxIL4A2liQPlaZ0rgCEwYBhgL/s1600/Asbestos%2BExposure%2B-%2BAsbestosis%252C%2BFibrosis.png" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img alt="Asbestos Exposure - Asbestosis, Fibrosis" border="0" data-original-height="146" data-original-width="225" src="https://4.bp.blogspot.com/-VYtFznK3niM/WU2jDpHF2rI/AAAAAAAAAEE/bioUOpVs1yUekH8pGxIL4A2liQPlaZ0rgCEwYBhgL/s1600/Asbestos%2BExposure%2B-%2BAsbestosis%252C%2BFibrosis.png" title="Asbestos Exposure - Asbestosis, Fibrosis" /></a></div><h3>Etiology</h3><br />A unique feature of mesothelioma is its strong relationship with asbestos exposure, which has recently led to great public concern in view of the ubiquitous presence of that mineral.<br /><br /><h3>Epidemiologic and Clinical Evidence of the Role of Asbestos</h3><br />Many epidemiologic surveys around the world have revealed prior exposure to asbestos in about 70 to 80% of all cases of mesothelioma when a careful history was taken.16,63,192,305 Beginning 15 years after onset of exposure, about 6% of asbestos workers over the age of 35 years die of mesothelioma.238 The death rate from mesothelioma in a cohort of asbestos insulation workers was 344 times higher than in the general population.236<br /><br />It is estimated that, from 1940 through 1979, approximately 27.5 million workers were occupationally exposed to asbestos in the United States, with a calculated annual death rate from mesothelioma of about 2,000 in 1980 up to 3,000 in the late 1990s.190 Exposure can be not only occupational but also environmental, or even familial by household contamination. The latter type of exposure, usually through the work clothes of an asbestos worker, is an important factor for women. It was also found in 5 of 10 young adults (40 years or younger) with mesothelioma who had been exposed in childhood.134 Insulation, construction, shipyard industries, and automobile brakes are among the many sources of occupational exposure. The delay between first exposure and onset of the disease is extremely long, averaging 30 to 45 years, with a usual range of 10 to 65 years and a standard deviation of 12 years.63,238,305 Because of such a delay, asbestos exposure can easily be underestimated, since occupational histories are often inadequately documented.<br /><br />197,280 Moreover, exposure may have been short or minimal, 63,238 although sometimes a very short exposure may have been intense.306 Pulmonary asbestosis and fibrosis are often absent or are rarely severe and are found at autopsy in about 40% of patients with mesothelioma.16,63 Due to the long latency and to the vastly increased use of asbestos during and after World War II, the incidence of mesothelioma is expected to continue to increase.190 Although asbestos exposure and cigarette smoking act synergistically to produce bronchogenic carcinoma, smoking is not a factor for mesothelioma.183,192,238,291 The presence of asbestos fibers in sections of lung tissue is another proof of asbestos exposure. Asbestos fibers are more difficult to detect in mesothelioma tissues than in the pulmonary parenchyma. Fibers in tissues can acquire a proteinaceous coating containing iron, leading to the formation of ferruginous bodies.238 These are not specific and can be called asbestos bodies only if the central core is identified as being asbestos. The asbestos minerals are divided into two major categories: the serpentines (chrysotile) with a general formula Mg3Si2O5(OH)4, forming long hollow tubes, and the amphiboles containing more silica and less magnesium oxide and forming short, straight fibers.238 Among the various types of asbestos associated with mesothelioma, amphiboles carry the highest risk: crocidolite in South Africa, and amosite in the United States have been most commonly incriminated.<br /><br />127,183,293 Chrysotile, a long, curly fiber with poor pulmonary penetration which can be dissolved in lung tissue, seems to carry a much lower risk, although it does not appear to be nil.68,218,293 It has been postulated that mesotheliomas occurring in chrysotile-exposed individuals may be related to contamination by tremolite,68 another amphibole fiber which has been implicated in cases of mesothelioma in Greece,150 and which may contaminate other substances, such as talc or vermiculite.177 On the other hand, another amphibole fiber mined in Finland, anthophyllite, a thick coarse fiber, has been shown to cause calcified pleural plaques but usually not mesothelioma.127<br /><br />These data emphasize the importance of the type of fiber and its physical characteristics and also the fact that most natural asbestos fibers are rarely pure but mixed.127 Although asbestos fibers can be detected in essentially 100% of the lungs of city dwellers by using special techniques,151 their number is markedly greater in the lungs of patients with mesothelioma and occupational exposure to asbestos, commonly reaching several million fibers per gram of dry weight.16 This is particularly true when amphibole fibers are counted.183 The mean increase of lung fiber burden of mesothelioma patients as compared with controls was seven times higher for pleural and 16 times higher for peritoneal mesothelioma but was lower than for patients with asbestosis (48 times higher than controls) or lung cancer with asbestos exposure (32 times higher than controls).<br /><br />293 The question of a dose-response relationship between exposure to asbestos and occurrence of mesothelioma has been suggested by indirect methods, such as duration of employment in asbestos factories, or by quantitative measurements of pulmonary asbestos burden,63 especially if amphibole fibers > 10 microns are considered.218 No safe threshold has been established for asbestos exposure, however, and the asbestos burden in the lungs of mesothelioma patients forms a continuum that totally overlaps with controls at the lower end.219,306

Asbestos Exposure - Asbestosis, Fibrosis

Etiology A unique feature of mesothelioma is its strong relationship with asbestos exposure, which has recently led to great public concern ...

Read more »

Malignant Pleural Mesothelioma - Asbestos Product

<div class="separator" style="clear: both; text-align: center;"><a href="https://4.bp.blogspot.com/-x_wGC_K6Lh0/WU2eB3N4HbI/AAAAAAAAADo/I14qIxf4clEeP81Tw5e7ljGr2q2QPJu2QCLcBGAs/s1600/Malignant%2BPleural%2BMesothelioma%2B-%2BAsbestos%2BProduct.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img alt="Malignant Pleural Mesothelioma - Asbestos Product" border="0" data-original-height="305" data-original-width="406" height="240" src="https://4.bp.blogspot.com/-x_wGC_K6Lh0/WU2eB3N4HbI/AAAAAAAAADo/I14qIxf4clEeP81Tw5e7ljGr2q2QPJu2QCLcBGAs/s320/Malignant%2BPleural%2BMesothelioma%2B-%2BAsbestos%2BProduct.png" title="Malignant Pleural Mesothelioma - Asbestos Product" width="320" /></a></div><br /><h3>Mesothelioma Reference Center</h3><br />Our feature article “Mesothelioma: A Historical Perspective”, will give you a better understanding of the treatments available for anyone suffering from Mesothelioma.<br /><br />Mesothelioma affects the linings of the cavities around the lungs, stomach, and heart. It is caused by inhaling asbestos fibers, but the cancer usually does not appear until 10 to 40 years after a person first inhales asbestos.<br /><br />The existence of malignant mesothelioma as a primary tumor of the pleural, peritoneum, pericardium, and other organs has long been controversial. As early as 1767, however, Joseph Lieutaud is credited with describing two cases of probable mesothelioma in a study of 3,000 autopsies, and E. Wagner recognized the disease as a pathologic entity in 1870.238,239,298 Klemperer and Rabin described in detail the histologic features of benign (localized) and malignant (diffuse) mesotheliomas in 1931.143<br /><br />A case record of malignant pleural mesothelioma discussed in 1947 led neither to the recognition of the diagnosis nor to the suspicion of asbestos as a causative factor, even though the introductory sentence included the term asbestos worker, and later the patient's work was described as 'cutting asbestos insulating board."48 This controversy lasted until 1960, when the major etiologic factor (i.e., asbestos) was established in a seminal report by J. C. Wagner and colleagues in 32 of 33 cases of mesothelioma, largely by environmental exposure in the 'Asbestos Hills" of Cape Province in South Africa.295 Such a singular relationship, confirmed in many other countries including the United States, established the disease as a distinct nosologic entity.236<br /><br /><h3>Incidence and Epidemiology</h3><br />Mesothelioma has been such a rare disease, or one recognized so infrequently, that it has not been coded as a separate cause of death and has been seriously underestimated in mortality statistics.71,236 The age-adjusted incidence of pleural and peritoneal mesothelioma in the United States has been estimated at 14.2 per million per year, with almost a three-fold increase for pleural mesothelioma in Caucasian males between 1973 and 1984.71 The male-female ratio is about 4:1, and 80% arise from the pleura.71 Cases tend to be clustered in areas of asbestos product plants and shipbuilding facilities.94 Similar trends have been reported in other industrialized countries, such as England. 104 In autopsy studies, the frequency of malignant mesothelioma varies from 0.02 to 0.7%, with a rate of 0.2% in the largest series.127<br /><br />In most hospital series, the pleura is more often involved than the peritoneum, with a predominance of the right side over the left (60:40).127 In some epidemiologic studies monitoring cohorts of asbestos workers, however, the peritoneal form is more common than the pleural.238 The mean age of patients is approximately 60 years,16,93,214,305 but the disease can occur at any age, including in childhood.116 In a review of 80 children with a diagnosis of malignant mesothelioma, the mean age was 9.7 years, and 59% were male. Only 2 children were noted to have a history of possible asbestos exposure, 1 had received radiotherapy for Wilms' tumor, and 1 had been exposed to isoniazid in utero.102<br /><br /><h3>Mesothelioma Treatments</h3><br />Traditional mesothelioma treatment options include surgery, chemotherapy and radiation therapy. Traditional treatments are also used to combat other types of cancer such as asbestos lung cancer, carcinomas, sarcomas, lymphomas, etc.<br /><br />New mesothelioma treatment options include new chemotherapy agents, photodynamic therapy (PDT), immunotherapy, mesothelioma gene therapy and intensity modulated radiation therapy (IMRT).

Malignant Pleural Mesothelioma - Asbestos Product

Mesothelioma Reference Center Our feature article “Mesothelioma: A Historical Perspective”, will give you a better understanding of the trea...

Read more »

Malignant Mesothelioma Surgery - Pericardial Mesothelioma

<div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-AbZG4cU2Ks8/WU2Z_F4k7oI/AAAAAAAAADc/DC-f473JnQAOiG3nvrUNntjfEofqBzCNQCEwYBhgL/s1600/Malignant%2BMesothelioma%2BSurgery%2B-%2BPericardial%2BMesothelioma.png" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img alt="Malignant Mesothelioma Surgery - Pericardial Mesothelioma" border="0" data-original-height="283" data-original-width="251" src="https://1.bp.blogspot.com/-AbZG4cU2Ks8/WU2Z_F4k7oI/AAAAAAAAADc/DC-f473JnQAOiG3nvrUNntjfEofqBzCNQCEwYBhgL/s1600/Malignant%2BMesothelioma%2BSurgery%2B-%2BPericardial%2BMesothelioma.png" title="Malignant Mesothelioma Surgery - Pericardial Mesothelioma" /></a></div><h3>Potentially Curative Malignant Mesothelioma Surgery</h3><br />Malignant mesothelioma surgery has had limited success in treating this rare type of cancer. Malignant mesothelioma affects the mesothelial tissue of three large body cavities and is responsible for an estimated 200,000 deaths worldwide. A positive malignant mesothelioma diagnosis will yield one of three distinct types of the disease: pleural mesothelioma, peritoneal mesothelioma or pericardial mesothelioma.<br /><br />Malignant mesothelioma surgery is one of three traditional <a href="http://www.mesotheliomacancerweb.xyz/2017/06/mesothelioma-treatments-malignant.html" rel="nofollow" target="_blank">mesothelioma treatments</a>; chemotherapy and radiotherapy are the other two. Mesothelioma surgery is the most proactive of the treatments because it involves the physical removal of a cancerous mass from the body.<br /><br />There are three mesothelioma surgery categories:<br /><br /><ol><li>Diagnostic surgery: used to validate a mesothelioma diagnosis.</li><li>Palliative surgery: used to treat the symptoms of a disease as opposed to the disease itself.</li><li>Potentially curative surgery: administered with "curative intent" and often highly invasive.</li></ol><br /><h3>Mesothelioma Surgery -- Pleurectomy</h3><br />A pleurectomy decortication is the less invasive of the two types of potentially curative mesothelioma surgery. In short, a pleurectomy is a mesothelioma surgery through which the pleura (mesothelial tissue lining the lung cavity) is removed. Pleural mesothelioma causes cancerous cellular growth in the pleura and can spread (metastasize) to other parts of the body. Pleurectomy decortication surgery is an option only for early-stage pleural mesothelioma patients whose tumor has not yet invaded the lung tissue itself.<br /><br />Though potentially curative, pleurectomy decortication mesothelioma surgery is also used palliatively to treat some of the nagging symptoms associated with pleural mesothelioma. The procedure can help to reduce pain caused by pleural tumor mass or serve as a preventative measure against fluid build-up in the chest (pleural effusion), a common symptom of pleural mesothelioma.<br /><br /><h3>Extrapleural Pneumonectomy</h3><br />An extrapleural pneumonectomy is the more extensive and invasive of the two types of potentially curative mesothelioma surgery. An extrapleural pneumonectomy involves the removal of sections of the diaphragm and pericardium in addition to removal of the pleura and lung most affected by the cancer.<br /><br />An extrapleural pneumonectomy can require a hospital stay of five to ten days, during which patients will receive a variety of postoperative treatments designed to manage pain and rehabilitate affected organs (most notably the heart). Though an extreme measure, extrapleural pneumonectomy mesothelioma surgery has the potential to increase pleural mesothelioma patients' survival time by as much as five years.<br /><br />Pneumonectomy surgery is used to treat certain types of lung cancer, including asbestos lung cancer; however, a pneumonectomy strictly involves the removal of the diseased lung.<br /><br /><h3>Combination Therapy</h3><br />Mesothelioma surgery is typically used in conjunction with one or more additional mesothelioma treatments. Each mesothelioma treatment has its own technique for combating malignant mesothelioma cancer cells. It is believed that a combination of these various techniques provides a greater chance for treatment success.<br /><br />For example, chemotherapy treatment is often administered for several weeks to slow the spread of malignant mesothelioma cancer cells prior to surgical treatment. This is done with the intention of providing a certain degree of containment around the cancerous mass before removal. Radiation therapy is often used postoperatively to kill any lingering tumor cells. A three-pronged approach is more effective than removal of the tumor alone.

Malignant Mesothelioma Surgery - Pericardial Mesothelioma

Potentially Curative Malignant Mesothelioma Surgery Malignant mesothelioma surgery has had limited success in treating this rare type of can...

Read more »

Mesothelioma Treatments - Malignant Mesothelioma, Asbestos

<div class="separator" style="clear: both; text-align: center;"><a href="https://3.bp.blogspot.com/-H--ApN8PwMc/WU2VfHP-EgI/AAAAAAAAADQ/dE3PUJ2abo8A31yhlc2EXE8yUtZH5OvogCLcBGAs/s1600/Mesothelioma%2BTreatments%2B-%2BMalignant%2BMesothelioma%252C%2BAsbestos.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img alt="Mesothelioma Treatments - Malignant Mesothelioma, Asbestos" border="0" data-original-height="216" data-original-width="418" height="165" src="https://3.bp.blogspot.com/-H--ApN8PwMc/WU2VfHP-EgI/AAAAAAAAADQ/dE3PUJ2abo8A31yhlc2EXE8yUtZH5OvogCLcBGAs/s320/Mesothelioma%2BTreatments%2B-%2BMalignant%2BMesothelioma%252C%2BAsbestos.png" title="Mesothelioma Treatments - Malignant Mesothelioma, Asbestos" width="320" /></a></div><br />Mesothelioma treatments have been unsuccessful in combating malignant mesothelioma. The failure of mesothelioma treatments to eradicate the disease could be attributed to the short post-diagnosis survival time of malignant mesothelioma patients (one to two years). Once diagnosed, malignant mesothelioma is typically in an advanced stage, limiting the effect that mesothelioma treatments can have.<br /><br />Although asbestos lung cancer is often asymptomatic in its early stages, it can be diagnosed long before reaching an advanced stage. This creates a larger window of opportunity for treatment to take place, increasing treatment options. The longer a patient can receive treatment, the greater the chance of success.<br /><br /><h3>Traditional Mesothelioma Treatments</h3><br />Mesothelioma treatments are broken down into two categories: traditional treatments and new treatments.<br /><br />Traditional mesothelioma treatments are similar to other standard cancer treatment modalities. Two or more traditional mesothelioma treatments are often used together to better combat cancerous cells.<br /><br />Traditional mesothelioma treatments include:<br /><br /><ul><li>Surgery</li><li>Chemotherapy</li><li>Radiation therapy (radiotherapy)</li></ul><br /><h3>Surgery</h3><br />Surgical treatment is one of the oldest methods used to combat cancer. Surgical mesothelioma treatments involve the physical removal of a cancerous mass from a malignant mesothelioma patient.<br /><br />There are three categories of surgical treatment:<br /><br /><ul><li>Diagnostic surgery: used to provide a conclusive mesothelioma diagnosis. A biopsy is a diagnostic surgery that involves the surgical removal of diseased tissue for examination by a histopathologist.</li><li>Palliative surgery: used to treat a symptom of a disease without treating the disease itself. For example, fluid build-up in the chest (pleural effusion) is a common and painful symptom of pleural mesothelioma. A palliative surgical procedure treating pleural effusion is a thoracoscopy, the draining of fluid from the chest.</li><li>Potentially curative surgery: is performed with "curative intent," typically involving the removal of large amounts of diseased tissue. For example, an extrapleural pneumonectomy is a potentially curative mesothelioma surgery used to treat pleural mesothelioma. The highly invasive procedure involves the removal of cancerous pleural tissue in addition to an entire lung.</li></ul><br /><h3>Chemotherapy</h3><br />Chemotherapy mesothelioma treatments use chemical substances (drugs) to treat cancerous cells. Cancer cells are different from normal cells in that they divide and multiply in an uncontrolled fashion, allowing the disease to grow and spread rapidly. Anticancer chemotherapy drugs are developed to inhibit the spread of cancer by introducing elements of control to the otherwise uncontrollable cells.<br /><br />Cisplatin is a platinum-based chemotherapy drug used to treat a variety of cancers including sarcomas, carcinomas, lymphomas and mesothelioma (when in combination with other chemotherapy drugs). Cisplatin functions culminate in programmed cellular death (apoptosis) for targeted cancer cells by preventing rapidly dividing cells to duplicate DNA.<br /><br />New malignant mesothelioma treatments revolve primarily around the development and implementation of new chemotherapy drugs like Alimta (commonly used with cisplatin), Veglin and Onconase.<br /><br /><h3>Radiation Therapy (Radiotherapy)</h3><br />Radiotherapy mesothelioma treatments use high-energy particle beams (radiation waves) to kill cancerous cells. Radiotherapy is often used palliatively for the purpose of relieving certain malignant mesothelioma symptoms such as pain or shortness of breath.<br /><br />Radiation therapy can have a negative effect on healthy tissue surrounding treated cancer cells. Intensity modulated radiation therapy (IMRT) was therefore designed with the intention of providing a more targeted system of radiotherapy, limiting the amount of healthy tissue exposed to radiation.

Mesothelioma Treatments - Malignant Mesothelioma, Asbestos

Mesothelioma treatments have been unsuccessful in combating malignant mesothelioma. The failure of mesothelioma treatments to eradicate the ...

Read more »